Home » Trials » SLCTR/2025/030


Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI): A Randomized Clinical Trial

-

SLCTR Registration Number

SLCTR/2025/030


Date of Registration

20 Aug 2025

The date of last modification

Aug 20, 2025



Application Summary


Scientific Title of Trial

Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI): A Randomized Clinical Trial


Public Title of Trial

Randomized clinical trial to assess the effectiveness and the safety of single versus double stitch laparoscopic procedure (Burch Colposuspension) for women with Stress Urinary Incontinence


Disease or Health Condition(s) Studied

Stress urinary incontinence


Scientific Acronym

None


Public Acronym

None


Brief title

Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI)


Universal Trial Number

U1111-1320-9390


Any other number(s) assigned to the trial and issuing authority

Ref No: P/26/03/2025 ERC obtained from Faculty of Medicine, University of Kelaniya


Trial Details


What is the research question being addressed?

What is the efficacy and safety of one-stitch versus two-stitch laparoscopic Burch colposuspension in the surgical management of stress urinary incontinence (SUI)?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded : Participants, Data analysts, Outcome assessors


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Applicable


Intervention(s) planned

  1. Study Setting(s) The study will be conducted at the following locations: • Primary site: Professorial Gynaecology Unit, Colombo North Teaching Hospital (CNTH), Ragama. • Secondary sites: Gynaecological theatres and clinics at Hemas Hospital (Pvt) Ltd, Wattala, and Leesons Hospital (Pvt) Ltd, Ragama. Patient recruitment will occur through gynaecology outpatient clinics, patient assessment rooms, theatre admissions, and inpatient wards of the aforementioned hospitals.

  2. Randomization a. Method of Randomization into Study Arms • Block randomization will be used to ensure balance between the two arms throughout the study period. • Block size: A block size of 4 will be used to maintain equal distribution in each group. b. Unit of Randomization • The individual patient is the unit of randomization. c. Method of Sequence Generation • A computer-generated random sequence will be used to assign participants to either the one-stitch or two-stitch surgical group in a 1:1 ratio. d. Method of Allocation Concealment • Allocation will be concealed using sequentially numbered, sealed, opaque envelopes (SNOSE technique), prepared by an independent researcher not involved in the clinical care or outcome assessment.

  3. Intervention Details Intervention: • Surgical Procedure: Laparoscopic Burch colposuspension. Technique: • In the one-stitch group, a single non-absorbable No. 1.0 black silk suture will be placed bilaterally at the mid-urethral level and anchored to Cooper’s ligament. • In the two-stitch group, two non-absorbable No. 1.0 black silk sutures will be placed bilaterally—one at the mid-urethral level and one at the bladder neck level—and both anchored to Cooper’s ligament. Standardization: • All procedures will follow a standardized laparoscopic technique. • Patients will undergo general anaesthesia. • Operative and perioperative care (including pain management and catheterization) will be uniformly provided for both groups. Who Performs the Intervention: • All surgeries will be performed by experienced laparoscopic gynaecological surgeons affiliated with the study institutions, ensuring surgical consistency and technical expertise.

  4. Blinding Blinding procedures implemented in this RCT include: • Participants will not be informed of the specific surgical technique used. • Healthcare providers (surgeons) cannot be blinded due to the nature of the surgical intervention. • Data collectors and outcome adjudicators will remain blinded during follow-up assessments and data recording to minimize observer bias. • Data analysts will analyze de-identified data without knowledge of group assignments.


Inclusion criteria

• Adult women clinically diagnosed with stress urinary incontinence (SUI). • Consented for laparoscopic Burch colposuspension. • No prior surgical treatment for SUI. • Aged 30-70 years


Exclusion criteria

• Presence of urge incontinence or mixed incontinence with urge symptoms as the dominant component. • History of recurrent SUI, or grade >2 pelvic organ prolapse. • Contraindications to general anesthesia or laparoscopic surgery (e.g., severe obesity, significant comorbidities).



Primary outcome(s)

1.

Objective continence success: Absence of urinary leakage during a standardized pad test

[

6 and 12 months post-surgery.

]

Secondary outcome(s)

1.

Subjective continence success using a questionnaire

[

at 6 weeks,6 and 12 moths post-surgery

]
2.

Operative time (minutes).

[

during the surgey

]
3.

Early post-operative complications of laparoscopic Burch colposuspension. Retropubic bleeding/hematoma → tachycardia, falling Hb, suprapubic mass · Urinary retention/incomplete emptying (from over-elevation/edema) · Port-site issues: bleeding, infection; rarely early hernia · Ileus; unrecognized bowel/urinary tract injury presenting late with peritonitis or hematuria

[

During surgery –2 weeks

]
4.

Intermediate Post-operative complications of laparoscopic Burch colposuspension De novo urgency/urge incontinence (detrusor overactivity) · Voiding dysfunction/obstructive symptoms, high post-void residuals · Suture-related problems: intravesical/urethral suture → irritative LUTS, hematuria, calculus · Retropubic abscess or infected hematoma · Pelvic/suprapubic pain; neuropathic groin pain (ilioinguinal/genitofemoral entrapment) · Dyspareunia Late · Recurrent stress urinary incontinence (failure of suspension)

[

2 weeks –12 weeks

]
5.

Chronic post operative complications of Burch Coloposuspension Urinary retention/obstruction · Bladder/urethral erosion or, very rarely, fistula

[

After 2 weeks

]
6.

Patient satisfaction and quality-of-life improvement (measured using validated scales such as the International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form [ICIQ- UI SF]).

[

At 6 and 12 months post surgery

]

Target number/sample size

144 (72 per each group)


Countries of recruitment

Sri Lanka


Anticipated start date

2025-10-01


Anticipated end date

2027-12-31


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

Pending


Regulatory approvals

Sri lanka clinical trial registry



State of Ethics Review Approval


Status

Approved


Date of Approval

2025-05-14


Approval number

P/26/03/2025


Details of Ethics Review Committee

Name: Ethics Review Committee of the Faculty of Medicine, University of Kelaniya
Institutional Address: Faculty of Medicine, University of Kelaniya
Telephone:0112961000
Email: info.med@kln.ac.lk

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr.Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya

0775404921

prabathrandombage@gmail.com

Contact Person for Public Queries

Dr.Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya

0775404921

prabathrandombage@gmail.com


Primary study sponsor/organization

Dr. Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya
+94 775404921

prabathrandombagera@gmail.com

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

No


IPD sharing plan description


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results